Tango Therapeutics, Inc.

TNGX

NASDAQ

Healthcare

Biotechnology

Boston, MA, US155 employeestangotx.com

$21.66

+0.44(2.07%)

Mkt Cap $2.5B

$1.10

$21.63

52-Week Range

At A Glance

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer.

Revenue is primarily driven by Collaboration Revenue (87.9%) and License Revenue (12.1%).

Most recently: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 2, (2026-01-05).

$2.5B

Market Cap

$62M

Revenue

-$102M

Net Income

Employees155

Fundamentals

How The Business Makes Money

Revenue by Segment

Collaboration Revenue87.9%($124M)

License Revenue12.1%($17M)

Activity

What Changed Recently

Management Change

Jan 4, 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 2,

Financial Results

Mar 4, 2026

of this Current Report on Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or oth

Management Change+3 More

Jan 7, 2026

and 7.01 of this Current Report on Form 8-K and Exhibit 99.1 as well as Exhibit 99.2 attached hereto is being furnished and shall not be deemed “filed” for the

Peer Companies

Company	Price	Change	Market Cap	P/E
KODKodiak Sciences Inc.	$40.55	-5.28%	$2.1B	-5.4
NRIXNurix Therapeutics, Inc.	$15.51	+0.16%	$1.3B	-5.3
BCAXBicara Therapeutics Inc. ...	$21.48	+4.78%	$1.2B	-8.3
SEPNSepterna, Inc.	$25.20	+3.43%	$1.1B	-21.5
EYPTEyePoint Pharmaceuticals,...	$13.41	+3.00%	$1.1B	-4.6
XNCRXencor, Inc.	$12.79	+2.11%	$938M	-9.7
URGNUroGen Pharma Ltd.	$18.84	-0.53%	$917M	-5.5
FTREFortrea Holdings Inc.	$9.46	-0.58%	$884M	-0.9

Analyst View

Company Profile

CIK0001819133

ISINUS87583X1090

CUSIP87583X109

Phone857 320 4900

Address100 Binney Street, Boston, MA, 02142, US

SEC EDGAR